Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFiltronic Regulatory News (FTC)

Share Price Information for Filtronic (FTC)

Share Price is delayed by 15 minutes
Get Live Data
352.50    -50.00 (-12.82%)
Bid:
350.00
Ask:
355.00
Spread: 5.00 (1.429%)
Market Cap: £747.81m
FTC Live PriceLast checked at - London Stock Exchange

Intraday Filtronic Share Chart

Year-End Trading Update

30 Jun 2020 07:00

RNS Number : 4509R
Filtronic PLC
30 June 2020
 

 

30 June 2020

Filtronic plc

(the "Company" or the "Group")

 

TRADING UPDATE

 

Filtronic plc (AIM: FTC), the designer and manufacturer of products for the critical communications, wireless telecoms and defence & aerospace markets, is pleased to provide the following trading update for the financial year ended 31 May 2020 ("FY2020").

 

Antenna Business Sale

As previously reported, the Telecoms Antenna Operation was sold during December 2019 and the sale completed in January 2020. All transitional arrangements agreed with the buyer have now been satisfactorily completed. Consequently, the numbers presented below represent only the continuing operations of the Group.

 

Financial Highlights

Trading during the second half of the year was broadly in line with market guidance despite some Covid-19 related disruption in the final quarter. The Board therefore expects, subject to audit, to report FY2020 revenue of approximately £17.2m (FY2019: £15.9m), representing growth of 8%, adjusted operating profit of approximately £0.4m (FY2019: £0.2m) and adjusted earnings before interest, taxation, depreciation, amortisation and exceptional items ("EBITDA") of £1.2m (FY2019: £0.7m ). Cash at bank at 30 May 2020 was £2.0m (30 Nov 2019: £0.1m). Net cash (net of all lease obligations except right of use property leases) at 31 May 2020 was £0.7m (30 Nov 2019: net debt of £2.2m).

 

Operational Highlights

A strong order book entering the second half of the financial year sustained the business during the Covid-19 crisis. In February 2020 the Company established a Covid Business Continuity Team with the purpose of providing and sustaining a fully compliant and safe working environment whilst maintaining full operational capacity to fulfil customer commitments. The Company is pleased to report that it maintained a 24/7 manufacturing capability throughout the period whilst all employees who could work from home were enabled to do so. The extensive measures taken to ensure staff safety, naturally came at a cost for adjustments to operational layouts and processes, operational efficiency and additional headcount. However, most importantly, the Company experienced zero confirmed Covid-19 related staff sickness whilst the average employee attendance rate during the last quarter of the period was over 98%. The support of our entire staff must be recorded as having been exemplary and we are grateful to all of them for their resilience and hard work during a difficult time for everybody.

 

We continued to receive orders from existing clients during the period but constraints imposed by Covid-19 slowed the rate of new business acquisition and development activities. As year-end approached, we were advised of a short-term delay to two key client delivery schedules. We responded to this by implementing a furlough programme for a number of manufacturing staff from early June and expect to recall these employees progressively during July and August. We did not however suffer any order cancellations or deterioration in commercial terms.

 

Our new self-calibrating Tower Top Amplifier product for the US Public Safety Communications market was launched as planned and has been adopted by our lead client, from whom we expect the first orders in early FY2021. Our new 5G X-Haul Transceiver product (Morpheus, replacing Orpheus) was also qualified by and launched to our lead X-Haul client during the period and we anticipate the first production units to ship in late summer 2020.

 

Outlook

There is considerable uncertainty in both the macroeconomic environment and the markets in which we operate. As the focus of concern regarding the impact of Covid-19 progressively shifts from public health to the economy, that uncertainty will increase. Whilst we have entered FY2021 with a good order book, it would be imprudent to be anything other than cautious on the outlook for the year ahead and consequently, in common with many of our peers, we will not be providing guidance for the expected performance of the business at this time.

 

We expect to release our Preliminary Results on 4 August.

 

Enquiries:

Filtronic plc

Tel. 0113 220 0000 or investor.relations@filtronic.com

Reg Gott (Executive Chairman)

Michael Tyerman (Chief Financial Officer)

finnCap Limited

Tel. 020 7220 0500

Jonny Franklin-Adams / Hannah Boros (Corporate Finance)

Alice Lane / Sunila de Silva (ECM)

Walbrook PR Limited

Tel. 020 7933 8780 / 07768 807631

or filtronic@walbrookpr.com

Paul Vann

 

Notes:

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTDDGDLXGDDGGC
Date   Source Headline
27th May 20267:00 amRNSHolding(s) in Company
18th May 20265:32 pmRNSHolding(s) in Company
29th Apr 20267:00 amRNSHolding(s) in Company
24th Apr 20269:08 amRNSDirector/PDMR Shareholding
21st Apr 202612:19 pmRNSDirector/PDMR Shareholding
17th Apr 20264:00 pmRNSHolding(s) in Company
9th Apr 20262:10 pmRNSDirector/PDMR Shareholding
1st Apr 20267:00 amRNS-RNew contract with major European defence prime
26th Mar 20267:00 amRNS$8.0m contract win with US Company
18th Mar 20264:55 pmRNSHolding(s) in Company
2nd Mar 20267:30 amRNSChange of Registered Office
25th Feb 20262:21 pmRNSHolding(s) in Company
9th Feb 20265:02 pmRNSHoldings in Company
3rd Feb 20267:00 amRNSInterim Results
29th Jan 20268:25 amRNSAppointment of Joint Corporate Broker
15th Dec 20257:00 amRNSMajor European defence prime selects Filtronic
12th Dec 20257:00 amRNSHalf year trading update
3rd Dec 202510:00 amRNS-RNSIP funding to develop high-power amplifier
10th Nov 202510:33 amRNSExercise of Options and Total Voting Rights
6th Nov 20257:00 amRNS€7m contract for satellite constellation programme
30th Oct 20254:12 pmRNSRESULT OF ANNUAL GENERAL MEETING
30th Oct 20257:00 amRNSAGM Trading Update and Notice of Results
23rd Sep 20259:21 amRNSPublication of Annual Report and Notice of AGM
28th Aug 20255:20 pmRNSExercise of Options, Director Dealing and TVR
26th Aug 20257:00 amRNSNew $62.5m order with SpaceX
11th Aug 20252:20 pmRNSHolding(s) in Company
29th Jul 20257:00 amRNSFinal Results
24th Jul 202510:48 amRNSExercise of Options and Total Voting Rights
15th Jul 202512:16 pmRNSHolding(s) in Company
14th Jul 20257:00 amRNSNew £13.4m contract award for Defence prime
9th Jul 202512:10 pmRNSHolding(s) in Company
25th Jun 20257:00 amRNSYear End Trading Update and Notice of Results
19th Jun 202511:26 amRNSHolding(s) in Company
18th Jun 202512:26 pmRNSHolding(s) in Company
13th Jun 20255:44 pmRNSHolding(s) in Company
12th Jun 202510:45 amRNSHolding(s) in Company
12th Jun 20259:01 amRNSHolding(s) in Company
10th Jun 20257:00 amRNSLargest contract award to date with SpaceX
29th May 20257:00 amRNSNew contract with defence prime Leonardo
20th May 20252:40 pmRNSTR - 1
15th May 20257:00 amRNSNew Airbus Constellation Satellites Contract Award
6th May 20257:00 amRNSTrading Update
29th Apr 20253:44 pmRNSHolding(s) in Company
24th Apr 20257:00 amRNS-RNew Contract Award
9th Apr 20253:18 pmRNSDirector/PDMR Dealing
8th Apr 20253:53 pmRNSDirector/PDMR Dealing
2nd Apr 20253:19 pmRNSDirector/PDMR Shareholding
27th Mar 20258:50 amRNSDirector/PDMR Dealing
19th Mar 20257:00 amRNSFiltronic Expands Strategic Agreement with SpaceX
7th Mar 20251:45 pmRNSExercise of Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.